Abstract:OBJECTIVE:To provide reference for improving the charge system of drug registration in China so as to promote work efficiency and quality of drug registration. METHODS:Through comparing the implementation of drug registration and evaluation in Japan and China(registration institution,process,cycle,etc.),Japanese charge standard of drug registration system was evaluated and its characteristics were analyzed,so as to put forward the suggestion for charge standard reform of drug registration in China. RESULTS & CONCLUSIONS:Japanese drug registration was internal review, with the independent administrative institution Pharmaceuticals and Medical Devices Agency(PMDA)as main body,combined with the opinions of the external experts;there was a strict control standard for the registration cycle. Specific fee was confirmed by the charge standard according to new drug registration,drug re-registration,first application,extension application,first or second category of drugs, orphan drugs or non-orphan drugs. Japanese charge standard was characterized with clear classification of charge standard,high fees, close relationship of charge level with drug types. The procedures for drug registration were more cumbersome in China,and involved more relevant institutions and personnel at different levels;there was not strict restriction on registration period;relatively rough charge standard,low fee and not detailed charge classification also existed. It is suggested to draw lessons from the experience for charge standard formulation and management of drug registration in Japan,improve the current drug registration charge system in China by adding charge standard of drug registration into annual report of Center for Drug Evaluation,raising the amount of fee, subdividing the charge items and setting up the feedback mechanism,which lay a solid foundation for improving the efficiency and quality of drug registration in China.

Registration and Regulatory Mode of API in China after Chemical Drug Registration Classification Reform

Influence of Chemical Drug Registration Reform on Pharmaceutical Industry in China

On the Amendments of China’s Provisions for Drug Registration

Tailored to fit: China optimizes policies and regulations regarding drug registration and review to promote innovation in traditional Chinese medicine

Overview on the Amendments of Provisions for Drug Registration in China

Review of Registration and Patent of Category 1.1 Chemical Drugs in China between October 2007 and September 2014

Review of Japanese Charge Standard for Drug Registration and Its Enlightenment to the Improvement of Corresponding Charge System in China

Application of drug patents in the classification and purchase of drugs in China

Discussion on the Intellectual Property Protection in the Drug Registration Regulations

Research approach for registration of classification 3 chemical drugs

Administrative Law Reform of Drug Review Regime in China

Regulation of Generic Drugs in China: Progress and Effect of the Reform of the Review and Approval System

The Influences of REACH Regulation on Pharmaceutical Industry in Our Country

Discussion on the Major Changes of Drug Administration Acceptance Review and Approval System

[Category of Chinese medicine registration:historical evolution,current status,and problems].

Reforming China's drug regulatory system

Recent Advances in Drug Development and Regulatory Science in China

Impact on drug quality by change of API sourcing

Access of Chinese Crude Drug to the USA Market

Evaluation on New Drug Registration System in America and Its Illumination for China

Solving Patent Problem in the Registration and Approval of Drugs